Meet Argenta

Argenta is a New Zealand-based international formulations R&D and manufacturing company. The company was formed in 2006 by Doug Cleverly, PhD, through the acquisition of Nufarm Health and Sciences, which manufactured animal health pharmaceuticals; and Chemlabs, an animal health research and development company. Argenta is known for its innovative formulations R&D as well as its manufacturing capabilities, which range from production of clinical trial material through commercial scale manufacturing and export. The acquisition of AlcheraBio has been an important step in Argenta’s U.S. expansion. In late 2011, Argenta began establishing a research and development facility at the Bioscience and Technology Business Center at Kansas University in Lawrence, Kansas, increasing Argenta’s presence in the US.

Argenta is currently made up of three entities:

  • Argenta Manufacturing, located in Auckland, NZ
  • Argenta Research, with headquarters in Auckland, NZ and a facility in Lawrence, Kansas
  • AlcheraBio LLC, with headquarters in Metuchen, New Jersey and a satellite office in Kansas City, Kansas

Click here for an interview with Dr. Doug Cleverly, founder and CEO of Argenta
Click here for a recent article about Argenta in BIOACTIVE, the journal of the NZBIO organization
Click here to visit the Argenta website
Argenta Global receives NZ Government Grant in Support of R&D. Click here.
Argenta CEO Receives Ernst & Young Entrepreneur of the Year Award. Click here.
Opportunities Abound in Biopharma (includes Argenta). Click here.

Argenta Q&A

What does Argenta do?
Argenta is a formulations R&D and manufacturing company that is well known in the animal health sector. As many people in the animal health industry know only too well, it is extremely difficult to find veterinary-drug-related formulations expertise, methods development, small-scale manufacturing and commercial-scale manufacturing in one place. Argenta solves that problem.

Argenta is a Contract Development and Manufacturing Organization (CDMO) formed in 2006. The company offers preformulation, formulation, and analytical development services including all activities required for the drug product component for the FDA/EMEA Chemistry, Manufacturing and Controls technical section. In addition, Argenta manufactures clinical trial material and commercial products to cGMP.

Argenta now exports to more than 35 countries, including the US and countries in Europe. For additional information about Argenta’s services, visit Argenta’s website at

What Is a CDMO?
CDMOs are companies that provide comprehensive, “one-stop shopping” from drug development through commercial-scale manufacturing.

How can AlcheraBio clients and potential clients benefit from the Argenta/ AlcheraBio relationship?
Many of AlcheraBio’s clients have projects with which Argenta can offer valuable assistance, for example, in pre-formulation and formulation development, analytical methods development, manufacture of clinical trial material, and commercial-scale manufacturing. AlcheraBio and Argenta worked together prior to the acquisition to create integrated development and regulatory plans on behalf of mutual clients. This allowed the two companies to see their synergies and, ultimately, to join forces to provide regulatory affairs, formulations, clinical studies, and manufacturing “one-stop shopping” for our clients.

Who are the key people at Argenta?
Argenta was founded and is headed by Dr. Doug Cleverly, a formulations chemist with significant experience in animal health. He formed Argenta in 2006 through the acquisition of the animal health operations of Nufarm Health and Sciences, and Chemlabs, an animal health research and development company. Dr. Cleverly and his senior management team are profiled HERE.